Distalmotion Secures $70 Million Loan for US Expansion

The robotics firm will use the funds to grow its presence in the US ambulatory surgery center market.

Updated on Oct. 21, 2026 in Robotics

Bold flat-color editorial illustration of a robotic surgical arm, evoking the precision of medical technology.
Distalmotion has secured a $70 million loan from Perceptive Advisors to accelerate the expansion of its DEXTER robotic system in the US. AI Illustration. Upload story photo >

Live Poll

Do you support the shift of complex robotic surgery services into local outpatient surgery centers?

Distalmotion has secured a $70 million senior secured term loan facility from Perceptive Advisors. The funding is intended to accelerate the company's US growth strategy for its DEXTER Robotic Surgery System.

Why it matters

This financing provides essential capital to support the adoption of DEXTER in ambulatory surgery centers across the United States. It also enables further research and development for the company's surgical robotics platform.

The DEXTER system utilizes a mobile robot design and single-use instruments, allowing for integration into centers without infrastructure modifications. It is currently authorized for adult surgeries including hernia repair and hysterectomy.

The players

Distalmotion

This Switzerland-based medical robotics company specializes in surgical systems designed for use in ambulatory surgery centers.

Perceptive Advisors

This investment firm provides capital to companies in the healthcare and life sciences sectors.

The details

Distalmotion designs its technology to bypass the need for sterile processing requirements while integrating seamlessly into existing medical facilities. The company operates a US office in Cleveland, Ohio, to facilitate its expansion into the domestic ambulatory market.

Timeline

  1. October 21, 2026: Distalmotion announced the secured loan facility.

The Tech Race

This move signals an intensifying competition to deploy robotic surgical technology into outpatient settings, replacing older, bulky systems that required extensive operating room modifications. By securing this capital, Distalmotion positions its DEXTER platform against established giants that have historically dominated the inpatient surgical robotics market.

Patients may see increased access to robotic-assisted procedures in local ambulatory surgery centers as the technology becomes easier for facilities to adopt. The shift toward mobile systems could streamline workflows for surgical staff by eliminating sterile processing needs.

The takeaway

The move underscores the growing trend of moving complex surgical procedures from traditional hospital settings to more accessible ambulatory centers. This shift relies on hardware innovations that prioritize portability and lower facility overhead costs.

Further reading

For more information on the evolving landscape of medical automation, visit our Robotics section.

More information

To learn more about the surgical platform, visit the Distalmotion corporate website.

Live Poll

Do you support the shift of complex robotic surgery services into local outpatient surgery centers?